$30,000 of BROWNSTEIN HYATT FARBER AND SCHRECK ON BEHALF OF ROYAL CARIBBEAN CRUISES LTD lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General issues related to cruise ship industry"
You can find more data on corporate lobbying on Quiver Quantitative.
RCL Congressional Stock Trading
Members of Congress have traded $RCL stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RCL stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 12/31.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
RCL Insider Trading Activity
RCL insiders have traded $RCL stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $RCL stock by insiders over the last 6 months:
- RICHARD D FAIN has made 0 purchases and 3 sales selling 16,000 shares for an estimated $4,976,286.
- VAGN O SORENSEN sold 10,300 shares for an estimated $3,399,412
- MARITZA GOMEZ MONTIEL sold 1,100 shares for an estimated $309,936
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
RCL Hedge Fund Activity
We have seen 568 institutional investors add shares of RCL stock to their portfolio, and 553 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 6,611,624 shares (-25.6%) from their portfolio in Q3 2025, for an estimated $2,139,389,293
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,540,491 shares (-99.4%) from their portfolio in Q3 2025, for an estimated $498,472,077
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 996,961 shares (-37.9%) from their portfolio in Q3 2025, for an estimated $322,596,640
- GOLDMAN SACHS GROUP INC added 969,574 shares (+52.4%) to their portfolio in Q3 2025, for an estimated $313,734,754
- BANK OF NEW YORK MELLON CORP removed 852,083 shares (-28.2%) from their portfolio in Q3 2025, for an estimated $275,717,017
- CAPITAL WORLD INVESTORS removed 843,439 shares (-4.7%) from their portfolio in Q3 2025, for an estimated $272,919,991
- PRICE T ROWE ASSOCIATES INC /MD/ added 751,170 shares (+85.9%) to their portfolio in Q3 2025, for an estimated $243,063,588
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
RCL Analyst Ratings
Wall Street analysts have issued reports on $RCL in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 02/02/2026
- Stifel issued a "Buy" rating on 01/30/2026
- Barclays issued a "Overweight" rating on 01/30/2026
- Goldman Sachs issued a "Buy" rating on 12/09/2025
- UBS issued a "Buy" rating on 11/12/2025
- Citigroup issued a "Buy" rating on 10/29/2025
- Tigress Financial issued a "Buy" rating on 08/21/2025
To track analyst ratings and price targets for RCL, check out Quiver Quantitative's $RCL forecast page.
RCL Price Targets
Multiple analysts have issued price targets for $RCL recently. We have seen 13 analysts offer price targets for $RCL in the last 6 months, with a median target of $370.0.
Here are some recent targets:
- Jamie Rollo from Morgan Stanley set a target price of $330.0 on 02/03/2026
- Trey Bowers from Wells Fargo set a target price of $383.0 on 02/02/2026
- Matthew Boss from JP Morgan set a target price of $371.0 on 02/02/2026
- Lizzie Dove from Goldman Sachs set a target price of $370.0 on 02/02/2026
- James Hardiman from Citigroup set a target price of $398.0 on 02/02/2026
- Brandt Montour from Barclays set a target price of $361.0 on 01/30/2026
- Steven Wieczynski from Stifel set a target price of $420.0 on 01/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
